These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2103572)

  • 1. Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Oct; 127(1):119-27. PubMed ID: 2103572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Mar; 124(3):397-402. PubMed ID: 2332716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cysteamine on the lysosomal enzymes of the hyperprolactinaemic rat pituitary.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Apr; 125(1):75-80. PubMed ID: 2110966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy of cysteamine in depleting prolactin immunoreactivity in different hyperprolactinemic animal models.
    Millard WJ; Romano TM
    Life Sci; 1991; 49(22):1635-42. PubMed ID: 1943468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained oestrogen-induced hyperprolactinaemia results from a pituitary defect.
    Willoughby JO; Pederick HJ; Jervois PM; Menadue MF
    J Endocrinol; 1983 Dec; 99(3):477-83. PubMed ID: 6196429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
    Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
    Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concanavalin-A-bound and -unbound prolactin in normal and hyperprolactinaemic rats.
    Champier J; Claustrat B; Harthe C; Chevallier P; Trouillas J
    J Endocrinol; 1992 Jul; 134(1):27-32. PubMed ID: 1500842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteamine acts immediately to inhibit prolactin release and induce cellular changes in estradiol-primed male rats.
    Saunders SL; Shin SH; Reifel CW
    Neuroendocrinology; 1984 Mar; 38(3):182-8. PubMed ID: 6325979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
    Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
    Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestradiol increases baseline growth hormone levels in the male rat: possible direct action on the pituitary.
    Carlsson L; Eriksson E; Seeman H; Jansson JO
    Acta Physiol Scand; 1987 Mar; 129(3):393-9. PubMed ID: 3577822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of xenoestrogen bisphenol A on uterine and pituitary weight, serum prolactin levels and immunoreactive prolactin cells in ovariectomized Wistar rats.
    Goloubkova T; Ribeiro MF; Rodrigues LP; Cecconello AL; Spritzer PM
    Arch Toxicol; 2000 Apr; 74(2):92-8. PubMed ID: 10839476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pituitary response to exogenous luteinizing hormone releasing factor in steroid-treated gonadectomized rats.
    Aiyer MS; Sood MC; Brown-Grant K
    J Endocrinol; 1976 May; 69(2):255-62. PubMed ID: 775006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phasic but not tonic pituitary secretion by 2-hydroxyoestrone in the rat: evidence of action as an oestrogen antagonist.
    Katayama S; Fishman J
    J Endocrinol; 1983 Jul; 98(1):103-12. PubMed ID: 6306131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
    Yanai R; Nagasawa H
    Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic effects of cysteamine on the rat adenohypophysis.
    Cairns PD; McComb DJ; Horvath E; Kovacs K; Milligan JV; Szabo S
    Exp Mol Pathol; 1984 Dec; 41(3):298-308. PubMed ID: 6510505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine depletes prolactin in young and old hyperprolactinemic rats.
    Simpkins JW; Estes KS; Millard WJ; Sagar SM; Martin JB
    Endocrinology; 1983 May; 112(5):1889-91. PubMed ID: 6832077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the progesterone antagonist mifepristone on the hypothalamo-hypophysial-ovarian axis in rats.
    van der Schoot P; Uilenbroek JT; Slappendel EJ
    J Endocrinol; 1990 Mar; 124(3):425-32. PubMed ID: 2159045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.